NOW APPROVED
NEW TRYPTYR: a first-in-class neuromodulator eye drop to treat THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE1-5
INDICATIONS AND USAGE
TRYPTYR (acoltremon ophthalmic solution) 0.003% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
IMPORTANT SAFETY INFORMATION
Warnings and Precautions
Potential for Eye Injury and Contamination: To avoid the potential for eye injury and contamination, advise patients not to touch the vial tip to the eye or other surfaces.
Use with Contact Lenses: TRYPTYR should not be administered while wearing contact lenses. If contact lenses are worn, they should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following administration.
Adverse Reactions
In clinical trials, the most common adverse reaction was instillation site pain (50%).
Please click here for the TRYPTYR Full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
REFERENCES
- TRYPTYR. Prescribing Information. Alcon, Inc.; 2025.
- Restasis. Prescribing Information. AbbVie; 2024.
- Xiidra. Prescribing Information. Bausch & Lomb; 2023.
- Tyrvaya. Prescribing Information. Oyster Point Pharma, Inc.; 2024.
Miebo. Prescribing Information. Bausch & Lomb; 2023.